RU2380361C2 - Способ получения производных 1,4-дифенилазетидинона - Google Patents

Способ получения производных 1,4-дифенилазетидинона Download PDF

Info

Publication number
RU2380361C2
RU2380361C2 RU2006145444/04A RU2006145444A RU2380361C2 RU 2380361 C2 RU2380361 C2 RU 2380361C2 RU 2006145444/04 A RU2006145444/04 A RU 2006145444/04A RU 2006145444 A RU2006145444 A RU 2006145444A RU 2380361 C2 RU2380361 C2 RU 2380361C2
Authority
RU
Russia
Prior art keywords
alkyl
aryl
general formula
cation
independently
Prior art date
Application number
RU2006145444/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2006145444A (ru
Inventor
Андреас ЛИНДЕНШМИДТ (DE)
Андреас Линденшмидт
Дэвид Уилльям УИЛЛ (DE)
Дэвид Уилльям УИЛЛ
Герхард ЙЕНЕ (DE)
Герхард ЙЕНЕ
Теодор Андреас ВОЛЛЬМАНН (DE)
Теодор Андреас ВОЛЛЬМАНН
Венделин ФРИК (DE)
Венделин Фрик
Бернд ЮНКЕР (DE)
Бернд ЮНКЕР
Давид РИГАЛЬ (DE)
Давид РИГАЛЬ
Гюнтер БИЛЛЕН (DE)
Гюнтер БИЛЛЕН
Хайнер ЙЕНДРАЛЛА (DE)
Хайнер ЙЕНДРАЛЛА
Original Assignee
Санофи-Авентис Дойчланд Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE200410025071 external-priority patent/DE102004025071B4/de
Priority claimed from DE102005010770A external-priority patent/DE102005010770A1/de
Application filed by Санофи-Авентис Дойчланд Гмбх filed Critical Санофи-Авентис Дойчланд Гмбх
Publication of RU2006145444A publication Critical patent/RU2006145444A/ru
Application granted granted Critical
Publication of RU2380361C2 publication Critical patent/RU2380361C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2006145444/04A 2004-05-21 2005-05-20 Способ получения производных 1,4-дифенилазетидинона RU2380361C2 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE200410025071 DE102004025071B4 (de) 2004-05-21 2004-05-21 Verfahren zur Herstellung von Diphenylazetidinon-Derivaten
DE102004025071.5 2004-05-21
DE102005010770A DE102005010770A1 (de) 2005-03-09 2005-03-09 Verfahren zur Herstellung von 1,4-Diphenylazetidinon-Derivaten
DE102005010770.2 2005-03-09

Publications (2)

Publication Number Publication Date
RU2006145444A RU2006145444A (ru) 2008-06-27
RU2380361C2 true RU2380361C2 (ru) 2010-01-27

Family

ID=37561403

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006145444/04A RU2380361C2 (ru) 2004-05-21 2005-05-20 Способ получения производных 1,4-дифенилазетидинона

Country Status (25)

Country Link
US (1) US7488818B2 (https=)
EP (1) EP1756049B1 (https=)
JP (1) JP2007538042A (https=)
KR (1) KR20070027554A (https=)
AR (1) AR049184A1 (https=)
AT (1) ATE376997T1 (https=)
AU (1) AU2005245124A1 (https=)
BR (1) BRPI0510150A (https=)
CA (1) CA2567149A1 (https=)
CY (1) CY1107425T1 (https=)
DE (1) DE502005001841D1 (https=)
DK (1) DK1756049T3 (https=)
ES (1) ES2294712T3 (https=)
HR (1) HRP20070570T3 (https=)
IL (1) IL178991A0 (https=)
MA (1) MA28635B1 (https=)
MX (1) MXPA06013456A (https=)
NZ (1) NZ551413A (https=)
PL (1) PL1756049T3 (https=)
PT (1) PT1756049E (https=)
RS (1) RS50539B (https=)
RU (1) RU2380361C2 (https=)
TW (1) TW200611896A (https=)
UY (1) UY28912A1 (https=)
WO (1) WO2005113496A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
CN100471835C (zh) * 2003-12-23 2009-03-25 默克公司 抗高胆固醇血症化合物
EP1699759B1 (en) 2003-12-23 2010-10-20 AstraZeneca AB Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
UY29607A1 (es) 2005-06-20 2007-01-31 Astrazeneca Ab Compuestos quimicos
MY148538A (en) 2005-06-22 2013-04-30 Astrazeneca Ab Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
TW200811098A (en) 2006-04-27 2008-03-01 Astrazeneca Ab Chemical compounds
US20090047716A1 (en) * 2007-06-07 2009-02-19 Nurit Perlman Reduction processes for the preparation of ezetimibe
EP2414529A2 (en) 2009-04-01 2012-02-08 Matrix Laboratories Ltd Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
WO2011056895A1 (en) * 2009-11-03 2011-05-12 University Of Notre Dame Du Lac Ionic liquids comprising heteraromatic anions
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
US9670237B2 (en) 2011-09-22 2017-06-06 Ut-Battelle, Llc Phosphonium-based ionic liquids and their use in the capture of polluting gases
WO2015048765A1 (en) 2013-09-30 2015-04-02 University Of Notre Dame Du Lac Compounds, complexes, compositions, methods and systems for heating and cooling
US10086331B2 (en) 2013-11-05 2018-10-02 University Of Notre Dame Du Lac Carbon dioxide capture using phase change ionic liquids
JP6803138B2 (ja) * 2014-10-22 2020-12-23 三星エスディアイ株式会社Samsung SDI Co., Ltd. ホスホニウム系化合物、それを含むエポキシ樹脂組成物、およびそれを用いて製造された半導体装置

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2138480C1 (ru) * 1993-09-21 1999-09-27 Шеринг Корпорейшн Производные азетидинона, фармацевтическая композиция с гипохолестеринемической активностью и способ снижения уровня холестерина в сыворотке

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2107548T3 (es) * 1991-07-23 1997-12-01 Schering Corp Compuestos de beta-lactama sustituidos utiles como agentes hipocolesterolemicos y procedimientos para su preparacion.
FI960095L (fi) * 1993-07-09 1996-01-09 Schering Corp Menetelmä atsetidinonien syntetitoimiseksi
HRP20030498A2 (en) * 2000-12-21 2005-04-30 Aventis Pharma Deutschland Gmbh Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
TWI291957B (en) * 2001-02-23 2008-01-01 Kotobuki Pharmaceutical Co Ltd Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2138480C1 (ru) * 1993-09-21 1999-09-27 Шеринг Корпорейшн Производные азетидинона, фармацевтическая композиция с гипохолестеринемической активностью и способ снижения уровня холестерина в сыворотке

Also Published As

Publication number Publication date
DE502005001841D1 (de) 2007-12-13
EP1756049A1 (de) 2007-02-28
KR20070027554A (ko) 2007-03-09
AR049184A1 (es) 2006-07-05
BRPI0510150A (pt) 2007-10-02
US20070149776A1 (en) 2007-06-28
TW200611896A (en) 2006-04-16
IL178991A0 (en) 2007-03-08
NZ551413A (en) 2009-07-31
MA28635B1 (fr) 2007-06-01
PT1756049E (pt) 2007-12-17
MXPA06013456A (es) 2007-03-01
WO2005113496A1 (de) 2005-12-01
US7488818B2 (en) 2009-02-10
JP2007538042A (ja) 2007-12-27
PL1756049T3 (pl) 2008-02-29
CA2567149A1 (en) 2005-12-01
CY1107425T1 (el) 2013-03-13
RS50539B (sr) 2010-05-07
AU2005245124A1 (en) 2005-12-01
RU2006145444A (ru) 2008-06-27
ES2294712T3 (es) 2008-04-01
EP1756049B1 (de) 2007-10-31
DK1756049T3 (da) 2008-02-25
HRP20070570T3 (en) 2008-01-31
ATE376997T1 (de) 2007-11-15
UY28912A1 (es) 2005-12-30
HK1103296A1 (zh) 2007-12-14

Similar Documents

Publication Publication Date Title
RU2380361C2 (ru) Способ получения производных 1,4-дифенилазетидинона
US6207822B1 (en) Process for the synthesis of azetidinones
HUP0501164A2 (en) New industrial process for the production of ezetimibe
KR101156588B1 (ko) 에제티밉의 제조방법 및 이에 사용되는 중간체
CN1060778C (zh) 头孢菌素衍生物
US4533660A (en) Antibacterial O-sulfated β-lactam hydroxamic acids
CN100509781C (zh) 制备1,4-二苯基氮杂环丁酮衍生物的方法
CN100347179C (zh) 经口给药用碳青霉素烯化合物的新的合成中间体及其制造方法
EP0589446B1 (en) N-(Hydroxyethyl)butanediamide derivatives as renin inhibitors
KR910005230B1 (ko) 아제티디논의 제조방법
HK1103296B (en) Method for producing 1,4-diphenyl azetidinone derivatives
JPS6019763A (ja) アゼチジノンチオエステル類の製造法
CN1041944A (zh) 青霉烯的制备方法
EP0100041B1 (en) 1-sulfo-2-azetidinone derivatives, their production and use
US9469610B2 (en) β-lactam compounds
JP2922943B2 (ja) イミダゾリジノン誘導体
KR890000226B1 (ko) 1-술포-2-옥소아제티딘 유도체의 제조방법
JP4372538B2 (ja) β−ヒドロキシエチルアミン化合物のオキサゾリジノン誘導体ならびにβ−ヒドロキシエチルアミン化合物の製造法
KR880000874B1 (ko) 1-술포-2-옥소아제티딘 유도체의 제조방법
DE102005010770A1 (de) Verfahren zur Herstellung von 1,4-Diphenylazetidinon-Derivaten
JPH0315627B2 (https=)
JPH0527636B2 (https=)
JPH047739B2 (https=)

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20110521